136 related articles for article (PubMed ID: 11003361)
21. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
Everlien H; Hockertz S
Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
[TBL] [Abstract][Full Text] [Related]
22. Visceral Leishmaniasis in renal transplant recipients: is it still a challenge to the nephrologist?
Sabbatini M; Pisani A; Ragosta A; Gallo R; Borrelli F; Cianciaruso B
Transplantation; 2002 Jan; 73(2):299-301. PubMed ID: 11821748
[TBL] [Abstract][Full Text] [Related]
23. Treatment of kala azar.
Ozsoylu S
Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
[No Abstract] [Full Text] [Related]
24. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure.
Esteban RJ; Bravo JA; Osuna A; Asensio C
Nephrol Dial Transplant; 1996 Sep; 11(9):1898. PubMed ID: 8918659
[No Abstract] [Full Text] [Related]
25. Chemotherapy of experimental visceral leishmaniasis in the opossum.
White MR; Chapman WL; Hanson WL
J Parasitol; 1989 Feb; 75(1):176-8. PubMed ID: 2918440
[TBL] [Abstract][Full Text] [Related]
26. Meglumine antimoniate-induced pancreatitis.
Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
[No Abstract] [Full Text] [Related]
27. Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative.
Gómez Campderá F; Berenguer J; Anaya F; Rodriguez M; Valderrábano F
Am J Nephrol; 1998; 18(2):171. PubMed ID: 9569963
[No Abstract] [Full Text] [Related]
28. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
Borges MM; Pranchevicius MC; Noronha EF; Romero GA; Carranza-Tamayo CO
Rev Soc Bras Med Trop; 2017; 50(1):67-74. PubMed ID: 28327804
[TBL] [Abstract][Full Text] [Related]
29. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.
de Górgolas M; Castrillo JM; Fernández Guerrero ML
Clin Infect Dis; 1993 Jul; 17(1):56-58. PubMed ID: 8353246
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.
Halim MA; Alfurayh O; Kalin ME; Dammas S; al-Eisa A; Damanhouri G
Clin Infect Dis; 1993 Mar; 16(3):397-9. PubMed ID: 8135901
[TBL] [Abstract][Full Text] [Related]
31. [Visceral leishmaniasis: a study of 15 cases].
Laguna F; Gazapo E; Martínez P; Enriquez A; Puente S; García Aguado C; González Lahoz JM
An Med Interna; 1992 Apr; 9(4):161-4. PubMed ID: 1581449
[TBL] [Abstract][Full Text] [Related]
32. Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
Morizot G; Jouffroy R; Faye A; Chabert P; Belhouari K; Calin R; Charlier C; Miailhes P; Siriez JY; Mouri O; Yera H; Gilquin J; Tubiana R; Lanternier F; Mamzer MF; Legendre C; Peyramond D; Caumes E; Lortholary O; Buffet P
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004304. PubMed ID: 26735920
[TBL] [Abstract][Full Text] [Related]
33. Pancytopenia in a simultaneous pancreas and kidney transplant recipient: an unexpected cause - a case of visceral leishmaniasis in a transplant recipient.
Aardema H; Sijpkens YW; Visser LG
Clin Nephrol; 2009 Apr; 71(4):460-2. PubMed ID: 19356384
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.
Badaró R; Nascimento C; Carvalho JS; Badaró F; Russo D; Ho JL; Reed SG; Johnson WD; Jones TC
J Infect Dis; 1994 Aug; 170(2):413-8. PubMed ID: 8035028
[TBL] [Abstract][Full Text] [Related]
35. The hunt for an elusive source of pyrexia in a foreign worker.
Lew JW; Koh CK; Selvan VS; Shen E
Singapore Med J; 2007 Apr; 48(4):e111-3. PubMed ID: 17384865
[TBL] [Abstract][Full Text] [Related]
36. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
[No Abstract] [Full Text] [Related]
37. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H
Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172
[TBL] [Abstract][Full Text] [Related]
38. Humoral factors during South American visceral leishmaniasis.
Pearson RD; Evans T; Wheeler DA; Naidu TG; De Alencar JE; Davis JS
Ann Trop Med Parasitol; 1986 Aug; 80(4):465-8. PubMed ID: 3789849
[No Abstract] [Full Text] [Related]
39. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
[TBL] [Abstract][Full Text] [Related]
40. Visceral Leishmaniasis After Kidney Transplant: An Unusual Presentation and Mode of Diagnosis.
Rana A; Gadde A; Lippi L; Bansal SB
Exp Clin Transplant; 2022 Mar; 20(3):311-315. PubMed ID: 34775939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
